The therapeutic applications of this combination generally include the management of various painful and inflammatory conditions.

What Dolokind Plus Treats: Main Uses and Benefits

The medication may be applied in addressing situations involving certain distressing symptoms across conditions presenting with disruptive symptom manifestations. It is commonly used to help with symptoms related to musculoskeletal and chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also relevant for easing acute pain in scenarios like dental pain, sprains and strains, and discomfort after minor surgical procedures.

Furthermore, the tablet is relevant for easing symptoms related to fever and generalized body aches, and managing episodic pain like menstrual cramps and headaches. By addressing these symptom clusters, the tablet contributes to improved comfort during symptomatic periods.

“The goal is to offer symptomatic relief that helps patients cope more steadily with symptom fluctuations.”

---

Quick Fact: Supportive Symptom Management

---

Eligibility Map: Who Can and Cannot Use Dolokind Plus

Official regulatory documents define strict criteria for the eligibility and non-eligibility of individuals to use Dolokind Plus (Aceclofenac/Paracetamol combination).

Age-Related Eligibility
Adults are the approved population for use.
Pediatric patients (under 18 years) are generally not recommended; safety and efficacy are not established [Source 3.4].
Elderly patients (over 65 years) must use the medicine with caution due to the increased risk of impaired organ function [Source 1.2].

Contraindicated Populations (Must Not Use)
Patients with hypersensitivity to Aceclofenac, Paracetamol, or a history of allergic reactions to Aspirin or other NSAIDs [Source 1.2].
Patients with severe hepatic (liver) or renal (kidney) failure [Source 1.2].
Patients with active peptic ulceration or gastrointestinal bleeding [Source 1.2].
Patients with severe heart failure (NYHA Class III/IV), established ischemic heart disease, or cerebrovascular disease [Source 2.4].
Pregnant patients in the third trimester [Source 1.2].

Conditional and Restricted Use
Patients with mild-to-moderate renal or hepatic impairment require caution and surveillance [Source 1.2].
The medicine is not recommended for women who are breastfeeding or those attempting to conceive [Source 1.4].

This structured eligibility profile is based entirely on the constraints listed in government-approved labeling, establishing clear criteria for use and absolute prohibitions for non-eligible populations.

Interactions with other medicines and products

This product is a combination of Aceclofenac (an NSAID) and Paracetamol. Its interaction profile reflects the documented risks associated with both active components, requiring careful monitoring when co-administered with specific medicinal products.

Product Category
Other NSAIDs, Corticosteroids, or Antiplatelet agents
Anticoagulants (e.g., Warfarin)
Anti-hypertensives (e.g., ACE Inhibitors, Diuretics)
Lithium, Digoxin, or Methotrexate
Immunosuppressants (e.g., Ciclosporin, Tacrolimus)
Hepatotoxic Drugs or Hepatic Enzyme Inducers

Co-administration with other NSAIDs (including COX-2 selective inhibitors) or systemic corticosteroids is generally discouraged due to an increased risk of gastrointestinal ulceration and bleeding. The drug may enhance the effect of oral anticoagulants, necessitating close monitoring of bleeding parameters.

The Aceclofenac component may reduce the effectiveness of diuretics and certain anti-hypertensives and can increase the plasma concentration of drugs like Lithium, Digoxin, and Methotrexate, which may lead to toxicity. The Paracetamol component carries an increased risk of toxicity when taken concurrently with other hepatotoxic medicines or substances that induce liver microsomal enzymes, including alcohol.

The mechanism of action for Dolokind Plus involves a dual-component strategy that modulates both peripheral and central pathways.

One component primarily functions through the inhibition of the cyclooxygenase (COX) enzyme system. It acts as a non-selective inhibitor, reducing the catalytic activity of both the constitutive COX-1 and the inducible COX-2 isoforms. This interaction blocks the conversion of arachidonic acid into various lipid mediators, including prostaglandins, thromboxanes, and prostacyclins. The resulting reduction in the synthesis of these local compounds modulates the initiation of nociceptive signaling at peripheral sites.

The second component modulates signaling predominantly within the Central Nervous System (CNS). Its activity includes influencing descending serotonergic pathways and potentially inhibiting prostaglandin synthesis within the brain and spinal cord. This action alters the perception of incoming signals at the spinal and supraspinal levels. The combined activity of peripheral enzymatic inhibition and central signal modulation results in a complex physiological consequence that influences the body's overall processing of sensory input.

The administration of Dolokind Plus (a combination containing diclofenac/aceclofenac and paracetamol) must strictly follow the official instructions provided by the prescribing physician and outlined in the product's regulatory documentation. Adherence to these guidelines is mandatory for correct use.

Official Administration Guidelines

Usage Domain	Official Regulatory Instruction	Practical Implication
Route of Administration	For oral administration, the tablets must be swallowed whole with a drink.	Do not crush, chew, or break the tablet.
Timing of Dose	Should be taken with or immediately after food or meals.	Taking it with food helps minimize the potential for stomach discomfort.
Dosing Schedule	The use of the lowest effective dose for the shortest duration necessary is recommended. Do not exceed the prescribed dose.	The physician determines the daily dose, typically 1 tablet two to three times daily.
Age Restriction	The pharmaceutical form and dosage are not indicated for children, typically those under 12 to 15 years of age.	This medication is generally restricted to use in adults and adolescents above the specified age limit.
Missed Dose	If a dose is missed, skip the missed dose and resume the regular dosing schedule. Do not take a double dose.	Resume the standard schedule without trying to compensate for the missed administration.

All doses must be taken precisely as directed by a healthcare professional. If the symptoms are more pronounced at night or in the morning, the evening tablet may be adjusted as instructed by the doctor. The overall use protocol is governed by the principle of lowest dose, shortest duration to achieve the desired effect.

Dolokind Plus: Recent Clinical Evidence

Combination Therapy Overview

Dolokind Plus is a fixed-dose combination agent containing Aceclofenac (a non-steroidal anti-inflammatory drug or NSAID) and Paracetamol (also known as Acetaminophen, an analgesic and antipyretic). Research in pain management often explores combination therapies to target different pain mechanisms simultaneously. The use of an NSAID with Paracetamol is a frequently studied approach for acute pain and inflammatory conditions.

---

Efficacy and Indications

Clinical trials and observational studies have primarily examined the use of this combination in the management of pain and inflammation associated with musculoskeletal and joint disorders, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Studies investigated the potential to influence pain scores and improve function in participants with these conditions.

• Acute Pain Models: Research has included assessments in acute pain models, such as post-surgical and dental pain, noting that the combination may be associated with a faster onset of pain relief compared to monotherapy in some settings.

---

Safety Profile and Research Gaps

Research regarding the agent’s safety profile has focused on monitoring adverse events. Commonly reported side effects in trials included gastrointestinal discomfort (such as nausea and diarrhea) and dizziness. The Aceclofenac component is associated with risks common to NSAIDs, while the Paracetamol component requires cautious use to avoid liver toxicity. Researchers stress the importance of following prescribed dosage to mitigate risks associated with both components.

Evidence regarding the agent’s long-term safety, particularly in individuals with pre-existing cardiovascular or severe kidney impairment, remains a critical area of ongoing investigation.

Common questions about Dolokind Plus (FAQ)

Q: How long does the effect of one dose of Dolokind Plus typically last?

A: Official product information, which includes data on how the medicine is processed by the body, indicates that the active ingredients have relatively short half-lives. Aceclofenac and Paracetamol are both eliminated from the body with a half-life of approximately 1 to 4 hours. This time frame gives a technical measure of how long the drug remains active in the body.

Q: Does Dolokind Plus cause drowsiness or make you sleepy?

A: Official regulatory documents report that the Aceclofenac component may be associated with side effects such as dizziness or drowsiness in some patients. Individual responses to the medicine can differ, as with any pharmaceutical product.

Q: Does Dolokind Plus have any effects on fertility?

A: According to official regulatory sources, the Aceclofenac component (an NSAID) may potentially impair female fertility. For this reason, official documentation states the medicine is not recommended for women attempting to conceive. Withdrawal of the drug is noted as a factor to be considered if difficulties in conceiving are experienced.

Q: Is it necessary to finish the entire course of Dolokind Plus as prescribed?

A: The guiding principle in regulatory documents for the NSAID component is to use the lowest effective dose for the shortest duration possible. The total length of treatment is determined by the prescriber. Official guidance notes that for conditions associated with long-term pain, the medicine may be continued as outlined by the healthcare provider.

Q: Is Dolokind Plus a muscle relaxant?

A: No, official regulatory classifications define Dolokind Plus as a fixed-dose combination of an Analgesic (pain reliever), an Antipyretic (fever reducer), and a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is not classified as a muscle relaxant.

Q: Does Dolokind Plus thin the blood?

A: Regulatory warnings indicate that the Aceclofenac component (an NSAID) may prolong blood clotting time and potentially increase the risk of bleeding. This action can also enhance the effect of oral anticoagulants (commonly called blood thinners), necessitating close monitoring of bleeding parameters according to official prescribing information.

Q: Is it safe to drive after taking Dolokind Plus?

A: Official product information warns that this medicine may cause side effects like dizziness, drowsiness, and visual disturbances in some patients. Regulatory documents state that driving or operating machinery are to be avoided if these side effects occur.

Q: Is it okay to take Dolokind Plus with milk?

A: Official guidance states that the medicine should be taken with or immediately after food to help minimize the potential for stomach discomfort. Some regulatory references specifically note that the tablet can be taken with milk or food for this purpose.

How to Store and Dispose of Dolokind Plus?

This section summarizes the official storage and disposal requirements for the medicine, strictly based on government regulatory documentation.

Storage and Handling Requirements	Official Regulatory Statement
Temperature and Environment	Store below 30°C in a cool and dry place.
Protection Requirements	Must be protected from light and moisture.
Child Safety	Keep out of the reach and sight of children and pets.
Stability Period	The documented shelf life is typically 24 to 36 months.

Official Disposal Rules

Regulatory agencies mandate specific end-of-life instructions to prevent environmental contamination:

1. Any unused or expired product and waste material must be disposed of in accordance with local requirements, typically via an approved waste disposal plant.
2. The medicine must not be flushed down the toilet, thrown into the drain, or allowed into any body of water, due to component toxicity to aquatic life.